​

Akero Therapeutics (AKRO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Akero Therapeutics Revenue Highlights

00

Akero Therapeutics Revenue by Period

Akero Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Akero Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Akero Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$4.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$284.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31--

Akero Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Akero Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ACADACADIA Pharmaceuticals$957.80M$278.63M
ACLXArcellx$107.94M$7.55M
KYMRKymera Therapeutics$47.07M$2.76M
NAMSNewAmsterdam Pharma$45.56M$19.14M
PRAXPraxis Precision Medicines$8.55M-
CRNXCrinetics Pharmaceuticals$1.04M$143.00K
AKROAkero Therapeutics--
SLNOSoleno Therapeutics-$66.02M
VKTXViking Therapeutics--
IMVTImmunovant--
CNTACentessa Pharmaceuticals--

AKRO Revenue FAQ

What is Akero Therapeutics’s yearly revenue?

Akero Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. AKRO's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Akero Therapeutics’s quarterly revenue?

Akero Therapeutics's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). AKRO's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Akero Therapeutics’s revenue growth rate?

Akero Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.